compound
5-Amino-1MQ (10 mg Vial) Questions Answered
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied for its metabolic effects in preclinical models [1] [2] .
5-Amino-1MQ (10 mg Vial)
Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 150 mcg 4.5 units (0.045 mL) Weeks 3–4 300 mcg 9.0 units (0.090 mL) Weeks 5–8 600 mcg 18 units (0.18 mL) Frequency: Inject once daily subcutaneously.
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied for its metabolic effects in preclinical models [1] [2] .
Week Daily Dose (mcg) Units (per injection) (mL) Weeks 1–2 150 mcg 4.5 units (0.045 mL) Weeks 3–4 300 mcg 9.0 units (0.090 mL) Weeks 5–8 600 mcg 18 units (0.18 mL) Frequency: Inject once daily subcutaneously.
Plan based on an 8–16 week daily protocol with gradual titration. Peptide Vials (5-Amino-1MQ, 10 mg each): 8 weeks ≈ 3 vials 12 weeks ≈ 4 vials 16 weeks ≈ 6 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syrin...
Practical considerations for consistency and safety. Use new sterile insulin syringes; dispose in a sharps container.